Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals
NCT ID: NCT02224716
Last Updated: 2015-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
968 participants
OBSERVATIONAL
2014-07-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
NCT00887276
Epidemiology and Current Practices in Severe Community-Acquired Pneumonia
NCT07301099
Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections
NCT01660204
Impact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired Pneumonia
NCT04158492
Usefulness of Microbiological Tests in Community-Acquired Pneumonia
NCT00312741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-intervention All patients admitted with a diagnosis of CAP
No interventions assigned to this group
Post intervention All patient admitted with a diagnosis of CAP
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18 years or more.
Exclusion Criteria
* Patients with severe immunosuppression (HIV infection with \<200 CD4+ lymphocytes / mm3), neutropenia (\<500 neutrophils / mm3).
* Patient treated with immunosuppressive drugs.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Pública Andaluza Progreso y Salud
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pilar Retamar Gentil
Role: STUDY_DIRECTOR
Hospital Universitario Virgen Macarena
Juan Enrique Corzo Delgado
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Virgen de Valme
Cristina Roca Oporto
Role: PRINCIPAL_INVESTIGATOR
Hospitales Universitarios Virgen del Rocío
Montserrat Pérez Pérez
Role: PRINCIPAL_INVESTIGATOR
Hospital de la Línea de la Concepción
Salvador López Cardenas
Role: PRINCIPAL_INVESTIGATOR
Hospital de Jerez de la Frontera
María del Carmen Almodóvar Pulido
Role: PRINCIPAL_INVESTIGATOR
Hospital de Antequera
Fernando Nebrera Navarro
Role: PRINCIPAL_INVESTIGATOR
Hospital de Formentera
Rosario Javier Martínez
Role: PRINCIPAL_INVESTIGATOR
University Hospital Virgen de las Nieves
Francisca Guerrero Sánchez
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Puerta del Mar
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación Pública Progreso y Salud
Seville, Sevilla, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FIS-ANT-2014-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.